[Infective endocarditis: update].
The pathogenesis of infective endocarditis (IE) is being dissected at the molecular level, which should help redefine new preventive and therapeutic strategies against IE. In spite of improving health care, the incidence of IE has not decreased over the last decades. While classical predisposing conditions such as rheumatic heart disease were being eradicated, new features of IE have emerged. These include IE in intravenous drug users, IE in elderly patients with sclerotic valve disease, prosthetic valve IE and nosocomial IE. The epidemiology, pathogenesis, diagnosis, prevention and treatment of IE are being reviewed in this article.
Que
Yok-Ai
YA
Division des soins intensifs de médecine, Département de Médecine interne, CHUV Lausanne. yque@chuv.hospvd.ch
Oddo
Mauro
M
Liaudet
Lucas
L
Moreillon
Philippe
P
D004697:Endocarditis, Bacterial / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D006801:Humans